News & Videos - OPPENHEIMER HLD.

Oppenheimer & Co. Inc. Appoints William Bird Director of Equity Research PR Newswire NEW YORK, April 3, 2024 Bird Has More Than 30 Years of Experience as a Top-Performing Analyst, Portfolio Manager and Management Strategy Consultant NEW YORK , April 3, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today the appointment of William Bird as Director of Equity Research. Bird,...

Il registra britannico ha ricevuto a sorpresa l'onorificenza da parte del re Carlo. La pellicola vincitrice dell'Oscar è arrivata anche ......

Oppenheimer Further Expands Public Finance Banking Team with Appointment of Frank Sanchez Reed As Head of the Southwest Region PR Newswire NEW YORK, March 12, 2024 Texas-Based Senior Banker, Who Has Nearly 30 Years of Public Finance Experience, Builds on Oppenheimer's Continued Momentum in the Space Reed's Recruitment Follows the Hires of Northeast Region Head Kristin Stephens, Southeast Region Head David Moffett and Public Finance Head Elizabeth Coolidge NEW YORK , March 12, 2024 /PRNewswire/...

...

Esther Ghey, the #mother of murdered teenager Brianna Ghey, has met the mother and #uncle of Scarlett Jenkinson, one of her ......

La 96esima edizione degli Academy Awards ha visto il trionfo di Oppenheimer: al colossal di Nolan sette statuette tra cui miglior ......

Suscríbete al podcast 'A por el Título' en ......

'Oppenheimer' se alza con siete óscares, incluidos los de Mejor Película, Mejor Director y Mejor Actor. 'La sociedad de la nieve', ......

...

IceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services Conference PR Newswire CAESAREA, Israel, March 7, 2024 CAESAREA, Israel , March 7, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that the Company's Chief Executive Officer, Eyal Shamir , will present...

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference PR Newswire ATLANTA, March 6, 2024 ATLANTA , March 6, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 34 th Annual Healthcare MedTech & Services Conference. The Company's virtual fireside chat is scheduled to begin at 10:40 a.m. ET on March 13, 2023...

Oppenheimer Holdings Inc. Announces Share Repurchase Program PR Newswire NEW YORK, March 4, 2024 NEW YORK , March 4, 2024 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE: OPY) today announced that its Board of Directors approved a share repurchase program that authorizes the Company to purchase up to 518,000 shares of the Company's Class A non-voting common stock, representing approximately 5% of its 10,357,376 currently issued and outstanding shares of Class A non-voting common stock. This...

SAN CLEMENTE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference. Details: Event Oppenheimer 34th Annual Healthcare MedTech & Services Conference Location Virtual Date Wednesday, March...

Le film de Christopher Nolan a notamment remporté les prix du meilleur film, du meilleur réalisateur et du meilleur acteur....

A Londra la serata dei Bafta premia soprattutto Oppenheimer e Povere Creature, che contano varie candidature agli Oscar di ......

Oppenheimer was the winner of the night at this year's BAFTAs, taking home seven awards, including the big one - best film....

Oppenheimer & Co. Inc. Announces 34th Annual Healthcare Life Sciences Conference PR Newswire NEW YORK, Feb. 13, 2024 Virtual Event Gathers Over 140 Leading Companies for Presentations and Fireside Chats, Hosted by Oppenheimer's Healthcare Equity Research Analysts Conference Combines In-Depth Discussions Between Executives and Investors With Oppenheimer's Expertise in Healthcare Research and Investment Banking NEW YORK , Feb. 13, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a...

Oppenheimer Further Expands Public Finance Banking Team with Appointments of Kristin Stephens and David Moffett PR Newswire NEW YORK, Feb. 8, 2024 Stephens will Head Up the Northeast Region while Moffett will Lead the Southeast Region; Each Has Over 20 Years of Public Finance and Municipal Capital Markets Experience, and will Serve as a Managing Director New York and Atlanta-Based Senior Hires Follow the Recent Recruitment of Their Colleagues and Oppenheimer's Newly Named Head of Public Finance,...

CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference PR Newswire LA JOLLA, Calif., Feb. 7, 2024 LA JOLLA, Calif. , Feb. 7, 2024 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced that Rachel Leheny , Ph.D., Chief Executive...

SAN DIEGO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will participate at the upcoming Oppenheimer 34 th Annual Healthcare Life Sciences Conference on February 13-14 and conduct a virtual presentation. The virtual presentation will take place...